Development and International Validation of a Novel Imaging-Based Risk Score (IsCHEMiA) for the Prediction of Poststroke Epilepsy
The IsCHEMiA score is an improved and readily applicable predictive model developed and validated using international stroke cohorts in the modern era of reperfusion therapies. It serves as a foundation for personalized management and may guide future clinical trials on antiepileptogenic therapies in acute ischemic stroke.
Authors
- Lori B. Chibnik (ORCID: https://orcid.org/0000-0001-6293-806X)
- Kazuki FUKUMA
- SF Pang
- I. S.M. Leung
- Gary K. K. Lau
- A Singhal
- Kay Cheong Teo (ORCID: https://orcid.org/0000-0002-3291-2958)
- Kin-Hung Liu
- Andrew J. Cole (ORCID: https://orcid.org/0000-0002-0828-826X)
- Jianing Wang (ORCID: https://orcid.org/0000-0002-6250-5245)
- Ryan Wui-hang Ho
- Rachel A. Donahue
- Wendy Leung
- A Wn Leung
- Yuen Kwun Wong
- Edwin Kin-Keung Yip
- Masafumi Ihara
- Tomotaka Tanaka
- Florinda Hui Ning Chu
- Kandace Chi Wing Chan
- Harrison T. Reeder
- Tommy Ho Fung Chung
Institutions
- Harvard University (US)
- Queen Mary Hospital (CN)
- Ruttonjee Hospital (CN)
- Massachusetts General Hospital (US)
- Cancer Research And Biostatistics (US)
- National Cerebral and Cardiovascular Center (JP)
- Baim Institute for Clinical Research (US)
- Cognitive Neuroimaging Lab (FR)
- University of Hong Kong (HK)
Publication Details
- Journal
- Neurology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1212/wnl.0000000000214486
- Citations
- 2
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 66.25